-- Bluebell Capital Partners has built a holding in Bayer and is now pushing for a governance overhaul and for a breakup of the company's agricultural and pharmaceutical divisions, Bloomberg reports citing unnamed sources.

-- Bluebell has also pressed Bayer to consider a sale of its consumer-health division and to appoint an independent chairman to its supervisory board, according to Bloomberg.

-- Bayer told Bloomberg that the company is always willing to engage constructively with stakeholders but declined to comment further. Bluebell declined to comment to Bloomberg.

Full story: https://bloom.bg/3X7T6dp

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

January 11, 2023 03:38 ET (08:38 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni Bayer (XE:BAYN)
Storico
Da Feb 2023 a Mar 2023 Clicca qui per i Grafici di Bayer
Grafico Azioni Bayer (XE:BAYN)
Storico
Da Mar 2022 a Mar 2023 Clicca qui per i Grafici di Bayer